Mode
Text Size
Log in / Sign up

Hyperbaric oxygen therapy associated with improved sleep quality in retrospective cohort study

Hyperbaric oxygen therapy associated with improved sleep quality in retrospective cohort study
Photo by National Cancer Institute / Unsplash
Key Takeaway
Consider HBOT-sleep association as preliminary; controlled trials needed for causality.

A retrospective longitudinal cohort study evaluated the effect of hyperbaric oxygen therapy (HBOT) on sleep quality in 395 patients at the Sagol Center. Participants included 180 healthy aging patients, 92 long COVID patients, and 123 PTSD patients. All received 60 HBOT sessions (2.0 ATA, 100% oxygen, 90 minutes, 5 days/week). No comparator group was reported.

The primary outcome was change in Pittsburgh Sleep Quality Index (PSQI) total score. Results showed PSQI total scores improved significantly in all three patient groups (p<0.001). Secondary outcomes included PSQI component scores, but specific effect sizes and absolute numerical changes were not reported. Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported.

Key limitations include the retrospective design and absence of a control group, which prevents establishing causality. Funding sources and conflicts of interest were not reported. The study's practice relevance is limited by its observational nature and lack of control data. These findings indicate an association between HBOT and improved sleep quality that should be interpreted cautiously pending randomized controlled trials.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedMar 2026
View Original Abstract ↓
BackgroundSleep disturbances are common in aging, post-traumatic stress disorder (PTSD), and long COVID, often linked to neuroinflammation, autonomic dysregulation, and neurodegeneration. Hyperbaric oxygen therapy (HBOT) promotes neuroplasticity through the hyperoxic-hypoxic paradox, improving cerebral perfusion, mitochondrial function, and reducing inflammation. While HBOT benefits sleep in certain conditions, its general effects across clinical populations remain unclear.MethodsThis retrospective longitudinal study evaluated Pittsburgh Sleep Quality Index (PSQI) changes in patients undergoing 60 HBOT sessions (2.0 ATA, 100% oxygen, 90 min, 5 days/week) at the Sagol Center. Participants included individuals treated for healthy aging (n = 180), long COVID (n = 92), or PTSD (n = 123). Pre- and post-treatment PSQI total and component scores were compared using paired t-tests and Wilcoxon signed-rank test was used for PSQI components. Regression analysis identified predictors of improvement.ResultsAmong 395 patients (mean age at baseline 57.9 ± 14.6 years, 31% female), baseline PSQI scores were highest in PTSD. Post-HBOT, total PSQI scores improved significantly in all groups (p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.